OrthoPediatrics Corp.

NASDAQ:KIDS

Medical - Devices

Healthcare
$31.65 +1.05%

+$0.19 today

Market cap
$826.40M
Beta
1.01
P/E (TTM)
-11.0
EPS (TTM)
-$1.68
52W Low $14.42High $23.70

Volume 0.16M

Average 0.16M

KIDS Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

OrthoPediatrics Corp.NASDAQ: KIDS

Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026

Accounts receivables dips below year-ago levels

Q1 FY2026 accounts receivables of $183K (cash outflow) fell 87.8% year over year, behind the +8.8% change in trailing-twelve-month accounts receivables. Sequentially, it fell 83.3% from the prior quarter. Over 3 fiscal years it compounded at +33.0% a year.

Context

  • Accounts receivables amounted to 4.0% of revenue in FY2025, up 1.6 pp from a year earlier.
  • Accounts receivables grew in size in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -87.8% toward the trailing-twelve-month pace of +8.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$183K-83.3% QoQ
Last fiscal yearDec 2025
-$9.37M+97.2% YoY
LTMMar 2026
-$8.05M+8.8% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-87.8%——
1 year+97.2%——
3-year CAGR+33.0%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
(9.37M) USD
Year-over-year change
-97.2%

Accounts Receivables vs competitors

How KIDS compares with its peers on the latest reported figures

  • KIDS's LTM Mar 2026 accounts receivables of $8.05M is the 4th largest of the 8 companies compared; the peer median is $2.6M.
  • Its year-over-year change of +8.8% is the 4th highest of 8, against a peer median of -48.4%.
  • Accounts receivables amounts to 3.3% of revenue for KIDS, versus a peer median of 2.1%.
KIDS Competitors Peer median
Accounts Receivables for KIDS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TOIThe Oncology Institute, Inc.LTM Mar 2026$11.73M -223.9%-13.8%2.1%
EOLSEvolus, Inc.LTM Mar 2026$8.53M -48.4%+7.0%2.8%
RXSTRxSight, Inc.LTM Mar 2026$8.52M +190.0%—6.7%
KIDSOrthoPediatrics Corp.LTM Mar 2026$8.05M +8.8%+33.0%3.3%
CBLLCeriBell, Inc.LTM Mar 2026$4.33M +27.2%+1.8%4.6%
BVSBioventus Inc.LTM Mar 2026$2.6M -979.1%-62.7%0.5%
LABStandard BioTools Inc.LTM Mar 2026$1.1M -82.4%—1.3%
TMCITreace Medical Concepts, Inc.LTM Mar 2026$306K +107.3%-42.6%0.1%
Peer median (excluding KIDS) $2.6M-48.4%-13.8%2.1%

Competitors are the stored peer set for KIDS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(16.26M)1.26M(20.97M)(37.82M)(39.65M)
Depreciation & Amortization10.68M13.1M17.39M19.08M21.12M
Deferred Income Tax(1.13M)(5.03M)(1.16M)(4.74M)(153K)
Stock-Based Compensation5.84M6.68M10.53M13.55M17.78M
Change in Working Capital(12.55M)(17.76M)(32.2M)(22.94M)(10.79M)
Accounts Receivables(466K)(3.98M)(9.72M)(4.75M)(9.37M)
Inventory(5.05M)(16.94M)(26.28M)(13.2M)(8.47M)
Accounts Payables(567K)(209K)1.49M(4.28M)8.17M
Other Working Capital(6.47M)3.37M2.32M(709K)(1.12M)
Other Non-Cash Items354K(20.01M)(623K)5.82M6.85M
Operating Cash Flow(13.06M)(21.77M)(27.05M)(27.05M)(4.85M)
Capital Expenditures(16.01M)(10.03M)(18.98M)(14.26M)(11.11M)
Acquisitions (Net)0(40.09M)(3.64M)(20.23M)(15.5M)
Purchases of Investments0(110.12M)(48.6M)(25.65M)(17.02M)
Sales of Investments9.25M46.87M112.9M49.86M0
Other Investing Activities(650K)0(2.11M)(2.88M)0
Investing Cash Flow(7.41M)(113.37M)41.68M(13.16M)(43.63M)
Debt Repayment(131K)(137K)9.28M56.54M23.98M
Common Stock Issued137K139.28M21K00
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities0(3.17M)(2M)(3.41M)0
Financing Cash Flow6K135.97M7.3M53.14M23.98M
Effect of Forex Changes(658K)619K633K(175K)348K
Net Change in Cash(21.13M)1.46M22.57M12.75M(24.16M)
Free Cash Flow(29.07M)(31.8M)(46.03M)(41.31M)(15.96M)

OrthoPediatrics Corp.

NASDAQ:KIDS

Intrinsic Alpha fair value

Locked

Current Price

$31.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.